Need to Know: Why Coke, others, may be spared, as a $100 billion opportunity in weight loss drugs unfolds says JPMorgan

<p>JPMorgan says the weight-loss drug industry is now a “$100 billion plus opportunity.” Coke is one of the stocks they say is likely to get hit less hard. Read Full Story</p>
<p>The post <a rel="nofollow" href="https://forextv.com/market-news/need-to-know-why-coke-others-may-be-spared-as-a-100-billion-opportunity-in-weight-loss-drugs-unfolds-says-jpmorgan/">Need to Know: Why Coke, others, may be spared, as a $100 billion opportunity in weight loss drugs unfolds says JPMorgan</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>